SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

BONDANELLI, Marta
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.250
AS - Asia 5.244
EU - Europa 4.176
SA - Sud America 873
AF - Africa 88
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
Totale 19.642
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.003
SG - Singapore 2.242
CN - Cina 1.617
DE - Germania 1.436
BR - Brasile 751
UA - Ucraina 677
IT - Italia 635
HK - Hong Kong 525
RU - Federazione Russa 334
GB - Regno Unito 317
TR - Turchia 308
FI - Finlandia 237
VN - Vietnam 235
PL - Polonia 150
SE - Svezia 137
MX - Messico 116
CA - Canada 104
FR - Francia 89
IN - India 64
ID - Indonesia 52
AR - Argentina 46
NL - Olanda 41
ZA - Sudafrica 40
BD - Bangladesh 38
JP - Giappone 38
ES - Italia 28
EC - Ecuador 25
BE - Belgio 23
IQ - Iraq 20
PK - Pakistan 18
AT - Austria 14
LT - Lituania 14
VE - Venezuela 12
MA - Marocco 11
PY - Paraguay 9
UZ - Uzbekistan 9
AE - Emirati Arabi Uniti 8
CL - Cile 8
MY - Malesia 8
TN - Tunisia 8
AU - Australia 7
CO - Colombia 7
CZ - Repubblica Ceca 7
IE - Irlanda 7
KE - Kenya 6
PA - Panama 6
SA - Arabia Saudita 6
UY - Uruguay 6
BO - Bolivia 5
DZ - Algeria 5
TH - Thailandia 5
CH - Svizzera 4
EG - Egitto 4
IL - Israele 4
IR - Iran 4
JM - Giamaica 4
JO - Giordania 4
KG - Kirghizistan 4
KR - Corea 4
LB - Libano 4
NP - Nepal 4
PS - Palestinian Territory 4
RO - Romania 4
TT - Trinidad e Tobago 4
AL - Albania 3
AZ - Azerbaigian 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
NG - Nigeria 3
NI - Nicaragua 3
PE - Perù 3
PH - Filippine 3
BB - Barbados 2
BG - Bulgaria 2
BY - Bielorussia 2
EU - Europa 2
GR - Grecia 2
GT - Guatemala 2
HU - Ungheria 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
OM - Oman 2
XK - ???statistics.table.value.countryCode.XK??? 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
GA - Gabon 1
GE - Georgia 1
GY - Guiana 1
HN - Honduras 1
KH - Cambogia 1
KW - Kuwait 1
LV - Lettonia 1
MC - Monaco 1
MD - Moldavia 1
MK - Macedonia 1
PT - Portogallo 1
Totale 19.631
Salva come PNG Salva come JPEG
Città #
Singapore 1.294
Woodbridge 905
Ashburn 888
Chandler 722
Jacksonville 675
Fairfield 604
Santa Clara 545
Beijing 541
Hong Kong 522
Houston 408
Ann Arbor 342
Wilmington 278
Seattle 219
Izmir 206
Nanjing 203
Addison 202
Cambridge 183
Munich 176
New York 170
Los Angeles 166
Princeton 155
Dallas 152
Warsaw 146
Milan 115
San Diego 94
Shanghai 85
Ho Chi Minh City 74
Mexico City 73
São Paulo 72
Shenyang 70
Boardman 66
Helsinki 64
Ferrara 61
Hanoi 56
Hebei 56
Hefei 55
Dearborn 50
Turku 47
Nanchang 46
Tianjin 43
Bremen 39
London 39
Changsha 38
Buffalo 36
Montreal 36
Chicago 35
Jakarta 35
Tokyo 32
Brooklyn 31
Jiaxing 30
Moscow 29
Denver 28
Orem 28
Phoenix 28
Kunming 27
San Francisco 27
Poplar 26
Stockholm 26
Chennai 25
Falls Church 25
Toronto 25
Washington 25
Jinan 24
Redwood City 24
Brussels 23
Mountain View 23
Rome 23
Boston 22
Atlanta 21
Johannesburg 21
Norwalk 21
Rio de Janeiro 21
Bologna 19
Manchester 19
Belo Horizonte 18
Zhengzhou 18
Frankfurt am Main 17
Falkenstein 16
Guangzhou 16
Ankara 15
Ningbo 15
Brasília 14
Campinas 14
Council Bluffs 14
San Mateo 14
Curitiba 13
Modena 13
Auburn Hills 12
Augusta 12
Haiphong 12
Amsterdam 11
Orange 11
Querétaro 11
Baghdad 10
Mumbai 10
Ottawa 10
Quito 10
Taizhou 10
The Dalles 10
Charlotte 9
Totale 12.095
Salva come PNG Salva come JPEG
Nome #
Control of pituitary adenoma cell proliferation by somatostatin analogs, dopamine agonists and novel chimeric compounds 284
Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression 222
Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism 217
Recettori della somatostatina e carcinoma midollare della tiroide: prospettive future. 205
Predictors of Pituitary Dysfunction in Patients Surviving Ischemic Stroke 200
Selective activation of somatostatin receptor subtypes differentially modulates secretion and viability in human medullary thyroid carcinoma primary cultures: potential clinical perspectives. 196
Protein Kinase C Delta restrains growth in ACTH-secreting pituitary adenoma cells 190
Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 189
Acromegaly is associated with increased cancer risk: a survey in Italy 183
IGF-I Proliferative Effects Are Inhibited by Targeting PKC in Human Endocrine Tumor Cells 177
An in vivo OctreoScan-negative adrenal pheochromocytoma expresses somatostatin receptors and responds to somatostatin analogs treatment in vitro 174
Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone (GH)- releasing hormone function 174
Efficacy and safety of the new 60 mg formulation of the long acting somatostatin analog lanreotide in the treatment of acromegaly. 173
Growth hormone excess promotes breast cancer chemoresistance 172
Acute administration of human galanin in normal subjects reduces the potentiating effect of pyridostigmine-induced cholinergic enhancement on release of norepinephrine and pancreatic polypeptide 171
Antiproliferative effects of somatostatin analogs in pituitary adenomas 169
Evaluation of hormonal function in a series of incidentally discovered adrenal masses 166
Diurnal rhythm of plasma catecholamines in acromegaly 166
Pituitary side effects of old and new drugs. 159
Recettori della Somatostatina e Carcinoma Midollare della Tiroide: prospettive future. 158
A new VHL polymorphism in a big family from Ferrara 158
Clinical value of different responses of serum thyroglobulin to recombinant human thyrotropin in the follow-up of patients with differentiated thyroid carcinoma 157
Role of the serotonergic system in the genesis of vasovagal syncope 155
Evaluation of bone markers and structure in subclinical Cushing’s syndrome 154
ADRENAL INCIDENTALOMA: CLINICAL AND METABOLIC ASPECTS DURING LONG-TERM FOLLOW-UP 154
In vitro testing of new somatostatin analogs on pituitary tumor cells 153
Cerebral aneurysm and acromegaly: a case report 153
Growth Hormone differentially modulates chemoresistance in human endometrial adenocarcinoma cell lines 153
Atypical femoral fractures as a complication of long-term bisphosphonate therapy 152
Efficacy of tolvaptan treatment in a patient with syndrome of inappropriate antidiuresis (SIAD) after severe traumatic brain injury 152
EFFECTS OF SOMATOSTATIN ANALOG TREATMENT ON GLUCOSE METABOLISM IN ACROMEGALY 151
L’iperplasia surrenale congenita e la pubertà precoce 151
Prevalence and predictive factors of anterior hypopituitarism after ischemic stroke. 151
Cardiac and metabolic effects of chronic GH and IGF1 excess in young adults with pituitary gigantism 151
Somatostatin receptor subtype 1 selective activation reduces cell growth and calcitonin secretion in a human medullary thyroid carcinoma cell line. 150
Thyroid papillary microcarcinoma: a descriptive and meta-analysis study 149
Effect of delta-opioid receptor agonist deltorphin on circulating concentrations of luteinizing hormone and follicle stimulating hormone in healthy fertile women 149
RISK FACTORS FOR DEVELOPING HYPOPITUITARISM AFTER STROKE 147
Efficay and safety of everolimus in metastatic gastroenteropancreatic neuroendocrine tumors 146
Post-stroke inflammatory response may influence pituitary function in patients with brain ischemic and hemorrhagic injury 145
Blood GH-binding protein levels in premenopausal and postmenopausal women: role of body weight and estrogen levels 144
Protein Kinase C: A Putative New Target for the Control of Human Medullary Thyroid Carcinoma Cell Proliferation in Vitro 144
Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fame 144
Le alterazioni pressorie nell'acromegalia: fattori umorali 143
Functional hypothalamic and drug-induced amenorrhea: an overview 143
Role of Piuitary Tumour Transforming Gene 1 in medullary thyroid carcinoma 142
Endogenous estrogen status significantly influences the nutrition-related alterations in Growth Hormone-Binding protein levles in healthy women 142
Glucose metabolism alterations in acromegaly 141
Dual-energy X-ray absorptiometry pitfalls in Thalassemia Major 141
Delta opioid receptor involvement in endocrine pathophysiology 140
Cerebrovascular disease and GH-IGF-i axis function 138
Prevalence of hyopituitarism in post-acute and chronic phase of hemorrhagic stroke 136
Inflammatory cytokines and neurotrophic factors correlate with pituitary function after stroke 136
ASSE GH-IGF-I NELL'INVECCHIAMENTO 134
A Novel PKC beta II Inhibitor Induces Antiproliferative Effects in Human Pancreatic Neuroendocrine Tumor Cells 134
ASYMPTOMATIC HYPERCALCITONINEMIA IN A PANCREATIC ENDOCRINE CARCINOMA ASSOCIATED WITH A PAPILLARY THYROID CANCER 134
Dopamine receptor 2 activation reduces cells viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion 132
Modulatory effect of the renin-angiotensin system on the plasma levels of calcitonin gene-related peptide in normal man 131
Multiple somatostatin receptor subtypes activation reduces cell viability in non-functioning pituitary adenomas by inhibiting Vascular Endothelial Growth Factor secretion 131
Interrelationships between calcitonin gene-related peptide and sympathoadrenomedullary system: Effects of administration of epinephrine and norepinephrine in healthy man 131
Replacement therapy and quality of life improvement in adult GHD patients 131
null 130
Prevalence of hypopituitarismin patients with cerebrovascular diseases 128
HypoparaNet: A Database of Chronic Hypoparathyroidism Based on Expert Medical-Surgical Centers in Italy 128
Bone metastases frequency, distribution, clinical and imaging characteristics in neuroendocrine tumors: our experience 127
Primary empty sella: Why and when to investigate hypothalamic-pituitary function 125
Human galanin reduces plasma norepinephrine levels in man 122
RELIABILITY OF QUANTITATIVE ULTRASOUND IN THE FOLLOW-UP OF ADULTS WITH GH DEFICIENCY UNDERGOING REPLACEMENT THERAPY 121
Systemic illness 120
INVECCHIAMENTO E GH 120
Follow-up dei pazienti sottoposti a terapia chirurgica per adenomi ipofisari non secernenti. 120
MEN1 gene sequence variant C.[527 G > A] P.[ARG 176 GLN]: Is it pathogenic? 120
PGH2 blocks the chemosensitizing effects of COX-2 inhibitors by a NF-KB mediated mechanism 119
Sistema Simpatoadrenomidollare nei pazienti acromegalici 119
null 118
Selective Cyclo-oxygenase 2 inhibitors revert chemoresistance In Medullary thyroid carcinoma by a mechanism mediated by P-gp and PGH2 118
Efficay and safety of teriparatide treatment 118
Predictors of morbidity and mortality in acromegaly: An Italian survey 118
Occurrence of pituitary dysfunction following traumatic brain injury 117
Effects of pasireotide on bronchial carcinoids in primary culture 117
Successful treatment with everolimus of functioning liver metastases from a pancreatic insulinoma 117
PATOLOGIA CEREBRALE ACQUISITA ED IPOPITUITARISMO 115
Regression of liver metastases of occult carcinoid tumor with slow release Lanreotide therapy 115
null 114
Role of GH-IGF-1 excess on periodontal tissues 114
Beta-thalassaemia major: Prevalence, risk factors and clinical consequences of hypercalciuria 113
null 113
FISIOPATOLOGIA, CLASSIFICAZIONE, PATOGENESI (ACROMEGALIA) 113
IPOPITUITARISMO E TRAUMA CRANICO. 112
Anterior pituitary function may predict functional and cognitive outcome in patients with traumatic brain injury undergoing rehabilitation. 112
Acromegaly in the elderly patients 112
Investigation of COVID‑19 infection in subjects with Klinefelter syndrome 112
Bariatric surgery in an obese patients with craniopharyngioma 111
null 111
GH-IGF-I deficit 110
Evidence for pituitary tumour transforming gene 1 (PTTG-1) expression and its possible oncogenic role in medullary thyroid carcinoma. 110
Evidence for integrity of the growth hormone/insulin-like growth factor-1 axis in patients with severe head trauma during rehabilitation 109
Clinica e diagnostica dei tumori neuroendocrini 109
Tumori neuroendocrini: i meccanismi fisiopatologici 109
Targeting PKC in human pancreatic neuroendocrine tumor cells 108
Totale 14.212
Salva come PNG Salva come JPEG
Categoria #
all - tutte 94.976
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 12.606
Totale 107.582
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021827 0 0 0 0 0 147 37 162 31 185 198 67
2021/20221.387 36 139 90 60 55 58 48 61 42 120 118 560
2022/20231.527 155 136 52 203 207 230 74 114 214 16 69 57
2023/2024834 68 95 50 25 51 176 25 79 25 24 24 192
2024/20253.452 99 76 267 106 419 359 129 131 579 428 483 376
2025/20265.130 939 384 800 1.162 1.615 230 0 0 0 0 0 0
Totale 19.829